Grieder F B, Davis N L, Aronson J F, Charles P C, Sellon D C, Suzuki K, Johnston R E
Department of Microbiology and Immunology, University of North Carolina at Chapel Hill 27599-7290.
Virology. 1995 Feb 1;206(2):994-1006. doi: 10.1006/viro.1995.1022.
The pathogenesis of Venezuelan equine encephalitis virus (VEE) was examined in the mouse model using V3000, a virus derived from a molecular clone of the Trinidad donkey strain of VEE. These results were compared in parallel experiments with avirulent mutants of VEE derived by site-directed mutagenesis of the clone. Adult mice, inoculated subcutaneously in their left rear footpad with V3000, were followed in a time course study for 6 days in which 15 organs were tested for histopathological changes, for the presence of viral antigen by immunohistochemical staining, for the presence of viral nucleic acid by in situ hybridization analysis, and for content of viable virus. Virus was detected in the footpad inoculation site, but until 12 hr postinoculation (pi), the level of virus did not suggest early viral replication. By 4 hr pi, however, replication of V3000 was evident in the draining popliteal lymph node. At this early time point, no virus could be isolated from any other organ examined. At 12 hr, a significant serum viremia was observed, and virus was detected at a low level in a number of well vascularized organs, including spleen, heart, lung, liver, kidney, and adrenal gland. By 18 hr, high virus titers were present in serum and all the lymphoid organs examined, and these tissues appeared to be the major peripheral sites of V3000 replication. Virus in serum and peripheral organs was cleared by 3-4 days pi. In a second phase of the infection, V3000 invaded the central nervous system (CNS), replicated predominantly in neurons, and persisted in the brain until death by encephalitis. Pathologic findings as well as the results of immunocytochemical and in situ hybridization examination were generally coordinate with virus titration. A site-directed mutant of V3000, V3010, contained a mutation in the gene for the E2 glycoprotein at codon 76 (Glu to Lys) which rendered it avirulent after footpad inoculation. Detection of V3010 replication in the draining lymph node was sporadic and was sometimes delayed to as long as 3 days pi. Infrequent and/or delayed virus spread to other sites also was observed. Analogous experiments were performed with other mutants which were avirulent by the footpad inoculation route: V3014, a mutant differing from V3000 at three loci (E2 Lys 209, E1 Thr 272, and E2 Asn 239), as well as single-site mutants V3032 (E2 Lys 209) and V3034 (E1 Thr 272).(ABSTRACT TRUNCATED AT 400 WORDS)
利用V3000(一种源自委内瑞拉马脑炎病毒特立尼达驴株分子克隆的病毒)在小鼠模型中研究了委内瑞拉马脑炎病毒(VEE)的发病机制。在平行实验中,将这些结果与通过对该克隆进行定点诱变获得的VEE无毒突变体进行了比较。给成年小鼠左后足垫皮下接种V3000,在一项为期6天的时间进程研究中对其进行跟踪,期间检测15个器官的组织病理学变化、通过免疫组织化学染色检测病毒抗原的存在、通过原位杂交分析检测病毒核酸的存在以及活病毒含量。在足垫接种部位检测到了病毒,但直到接种后12小时(pi),病毒水平并未表明早期病毒复制。然而,在接种后4小时,V3000在引流的腘淋巴结中明显复制。在这个早期时间点,从所检查的任何其他器官中都无法分离出病毒。在12小时时,观察到明显的血清病毒血症,并且在一些血管丰富的器官中检测到低水平的病毒,包括脾脏、心脏、肺、肝脏、肾脏和肾上腺。到18小时时,血清和所有检查的淋巴器官中都存在高病毒滴度,并且这些组织似乎是V3000复制的主要外周部位。血清和外周器官中的病毒在接种后3 - 4天被清除。在感染的第二阶段,V3000侵入中枢神经系统(CNS),主要在神经元中复制,并在脑中持续存在直至因脑炎死亡。病理结果以及免疫细胞化学和原位杂交检查的结果通常与病毒滴定结果一致。V3000的一个定点突变体V3010,其E2糖蛋白基因的第76位密码子发生突变(Glu突变为Lys),在足垫接种后变得无毒。在引流淋巴结中检测到V30I0的复制是零星的,有时会延迟到接种后3天。还观察到病毒向其他部位的传播不频繁和/或延迟。对其他通过足垫接种途径无毒的突变体进行了类似实验:V3014,一种在三个位点(E2 Lys 209、E1 Thr 272和E2 Asn 239)与V3000不同的突变体,以及单点突变体V3032(E2 Lys 209)和V3034(E1 Thr 272)。(摘要截短至400字)